Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403546
Status:
COMPLETED
Last Update Posted:
2017-06-06
First Post:
2006-11-21
Brief Title:
High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms
Sponsor:
Donald C Goff MD
Organization:
Massachusetts General Hospital